AQR Capital Management - PERNIX THERAPEUTICS HLDGS IN ownership

Quarter-by-quarter ownership
AQR Capital Management ownership history of PERNIX THERAPEUTICS HLDGS IN
ValueSharesWeighting
Q2 2016$645,000
-39.4%
1,439,596
+42.1%
0.00%
-50.0%
Q1 2016$1,064,000
-60.5%
1,013,108
+11.1%
0.00%
-60.0%
Q4 2015$2,691,000
+97.0%
912,196
+110.9%
0.01%
+66.7%
Q3 2015$1,366,000
+6.0%
432,466
+98.6%
0.00%0.0%
Q2 2015$1,289,000
+4.1%
217,785
+88.0%
0.00%0.0%
Q1 2015$1,238,000
-50.3%
115,855
-56.3%
0.00%
-40.0%
Q4 2014$2,489,000
+19.8%
265,055
-2.0%
0.01%
-16.7%
Q3 2014$2,077,000
+835.6%
270,400
+994.7%
0.01%
+500.0%
Q2 2014$222,00024,7000.00%
Other shareholders

There were no reported owners of PERNIX THERAPEUTICS HLDGS IN in Q3 2023.

NameSharesValueWeighting ↓
View complete list of PERNIX THERAPEUTICS HLDGS IN shareholders